CAR-M Technology: A Novel Approach to Overcome CAR-T Limitations in Solid Tumor Treatment
Researchers at the Korea Research Institute of Chemical Technology (KRICT), led by Dr. Chi Hoon Park, have successfully generated CAR-M (Chimeric Antigen Receptor Macrophages) by stably inserting synthetic genes into human macrophages derived from...
9-Apr-2025 12:00 AM EDT
Add to Favorites